SCHEMBL27100348

SCHEMBL27100348

CCN1CCN(Cc2cnc(NC(C)=O)s2)C(C)C1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 19/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079275 0.89 OGA (0.57) OGA
SCHEMBL30620432 0.88 OGA (0.73) OGA
SCHEMBL22079723 0.86 OGA (0.64) OGA
SCHEMBL22079362 0.85 OGA (0.66) OGA
SCHEMBL27100392 0.85 OGA (0.52) OGA
SCHEMBL22432786 0.83 OGA (0.62) OGA
SCHEMBL27008545 0.83 OGA (1.00) OGA
SCHEMBL27008654 0.82 OGA (1.00) OGA
SCHEMBL27008577 0.82 OGA (1.00) OGA
SCHEMBL27022324 0.82 OGA (1.00) OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327814-A2 MORPHOLINYL, PIPERAZINYL, OXAZEPANYL AND DIAZEPANYL O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITORS Biogen MA Inc. (US) 2024-02-28 — — EP disclosed
Send feedback